HSE and IPHA announce model Clinical Trial Agreement for tripartite clinical trials

29/05/2024

Update

Arthur Cox contributes to IBA’s Comparative Legal Guide on Telemedicine

09/06/2023

Publication

2023 Priority Legislation for Publication in the Life Sciences Sector

31/01/2023

Briefing

Cambrex Corporation acquisition of Q1 Scientific Limited

10/06/2022

Deals

Biosynth Carbosynth acquisition of Aalto Bio Reagents

30/05/2022

Deals

PRA Health Sciences proposed acquisition by ICON plc

24/02/2021

Deals

An Overview of the Communications Regulation Bill 2022

18/10/2022

Briefing

Arthur Cox contributes to ICLG Pharmaceutical Advertising 2022

13/07/2022

Publication

In Vitro Diagnostic Medical Devices Regulation enters into full effect

14/06/2022

Briefing

International Comparative Legal Guide: Digital Health 2022

03/03/2022

Publication

The Clinical Trial Regulation: Get Ready for Go-Live – Part 3

25/01/2022

Briefing

IPHA publishes new Framework Agreement on the Supply and Pricing of Medicines

13/01/2022

Briefing

The Clinical Trial Regulation: Get Ready for Go-Live – Part 2

10/01/2022

Briefing

The Clinical Trial Regulation: Get Ready for Go-Live – Part 1

14/12/2021

Briefing

IPHA model Clinical Trial Agreement

08/12/2021

Briefing

Arthur Cox contributes to ICLG Pharmaceutical Advertising 2021

15/07/2021

Publication

What you need to know about the new Regulation on transparency of risk assessment in the food chain

27/05/2021

Briefing

HPRA establish Compliance Programme on Advisory Boards

01/03/2021

Briefing

2021 priority legislation for publication in the Healthcare and Life Sciences sectors

11/02/2021

Briefing

Updates to the Irish Pharmaceutical Healthcare Association (“IPHA”) Codes

04/02/2021

Briefing

Impact of EU/UK Trade and Cooperation Agreement on Life Sciences Sector

29/01/2021

Briefing

Introducing the MCAP: Government rolls out new Medical Cannabis Access Programme

18/07/2019

Briefing